A prospective registration for newly diagnosed adults with primary immune thrombocytopenia (ITP) in Japan.

A prospective registration for newly diagnosed adults with primary immune thrombocytopenia (ITP) in Japan. - ITP-Registry in Japan

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000013855

Enrollment

200

Registered

2014-04-30

Start date

2014-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune Thrombocytopenia (ITP)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Recently-diagnosed (i.e. < 6 months) primary ITP adults patients (> 18 years) with platelet counts less than 100x109/L as defined by the International Working Group. This means that diagnosis of ITP should be within 6 months prior to enrolment into the registry. 2. Able to provide written consent for data to be included in the registry

Exclusion criteria

Exclusion criteria: Not Applicable

Design outcomes

Primary

Measure	Time frame
The disease course of ITP will be observed. This will include response assessment to each treatment modality, progression to refractory ITP, and the efficacy of any medical intervention (whether beneficial or detrimental) according to the overall severity of the disease, according to definitions described by the ITP International Working Group.	—

Countries

Japan

Contacts

Public ContactClinical and Translational Research Center

Keio University Hospital Clinical and Translational Research Center

dm-group@ctr.hosp.keio.ac.jp03-5363-3523

Outcome results